Literature DB >> 24166211

Validation of a Persian version of the Fibromyalgia Impact Questionnaire (FIQ-P).

Ali Bidari1, Morteza Hassanzadeh, Mohamad-Farzam Mohabat, Elham Talachian, Effat Merghati Khoei.   

Abstract

The aim of this study is to translate, adapt, and validate a Persian version of the Fibromyalgia (FM) Impact Questionnaire (FIQ-P). The FIQ-P was adapted following the translation and back-translation approach; then, it was administered to thirty females with FM. Participants also completed two other validated questionnaires, the Medical Outcome Survey Short Form-36 (SF-36) and the Beck Depression Inventory (BDI). Internal consistency within the FIQ-P items and its test-retest reliability were assessed with Cronbach's alpha and Spearman's correlation coefficient, respectively. Construct validity was analyzed by Spearman's r when correlating the FIQ-P to other questionnaires. The translated version was concordant. Adaptation affected two sub-items of physical function. Participants' mean age ± standard deviation was 40.4 ± 9.0 years. Internal consistency proved good with α = 0.80. Test-retest coefficient ranged from 0.50 for the item "work days missed" to 0.79 for all FIQ-P items. Fair and statistically significant (P < 0.01) correlations were found between the FIQ-P items and two other questionnaires, SF-36 (r = -0.57) and BDI (r = 0.53). We concluded that the FIQ-P is a valid and reliable instrument for measuring health status of Persian-speaking FM patients.

Entities:  

Mesh:

Year:  2013        PMID: 24166211     DOI: 10.1007/s00296-013-2883-0

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  31 in total

1.  The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

Authors:  J E Ware; C D Sherbourne
Journal:  Med Care       Date:  1992-06       Impact factor: 2.983

Review 2.  An analytical review of 24 controlled clinical trials for fibromyalgia syndrome (FMS).

Authors:  Kevin P White; Manfred Harth
Journal:  Pain       Date:  1996-02       Impact factor: 6.961

3.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

4.  Validation of a German version of the Fibromyalgia Impact Questionnaire (FIQ-G).

Authors:  M Offenbaecher; M Waltz; P Schoeps
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

5.  Development of the Japanese version of the Fibromyalgia Impact Questionnaire (JFIQ): psychometric assessments of reliability and validity.

Authors:  Kenichi Osada; Hiroshi Oka; Tatsuya Isomura; Ikuro Nakamura; Keiichiro Tominaga; Shinobu Takahashi; Ayako Kojima; Kusuki Nishioka
Journal:  Int J Rheum Dis       Date:  2011-02       Impact factor: 2.454

6.  The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia.

Authors:  J Rivera; T González
Journal:  Clin Exp Rheumatol       Date:  2004 Sep-Oct       Impact factor: 4.473

7.  Validation of an adapted arabic version of fibromyalgia syndrome impact questionnaire.

Authors:  Mai Abd El-Naby; Mohamed Ahmed Hefny; Ayman Ekram Fahim; Magdy Ahmed Awadalla
Journal:  Rheumatol Int       Date:  2013-05-17       Impact factor: 2.631

8.  Relationship of clinical features with psychological status in primary fibromyalgia.

Authors:  M B Yunus; T A Ahles; J C Aldag; A T Masi
Journal:  Arthritis Rheum       Date:  1991-01

9.  The fibromyalgia impact questionnaire: development and validation.

Authors:  C S Burckhardt; S R Clark; R M Bennett
Journal:  J Rheumatol       Date:  1991-05       Impact factor: 4.666

10.  The Fibromyalgia Impact Questionnaire, a Swedish translation of a new tool for evaluation of the fibromyalgia patient.

Authors:  P J Hedin; M Hamne; C S Burckhardt; A Engström-Laurent
Journal:  Scand J Rheumatol       Date:  1995       Impact factor: 3.641

View more
  5 in total

1.  The validity and reliability of the Persian version of the Revised Fibromyalgia Impact Questionnaire.

Authors:  Banafsheh Ghavidel Parsa; Alireza Amir Maafi; Afrooz Haghdoost; Yasaman Arabi; Monire Khojamli; Gelayol Chatrnour; Ali Bidari
Journal:  Rheumatol Int       Date:  2014-01-01       Impact factor: 2.631

2.  Validation of fibromyalgia survey questionnaire and polysymptomatic distress scale in a Persian population.

Authors:  Ali Bidari; Banafsheh Ghavidel-Parsa; Alireza Amir Maafi; Ali Montazeri; Babak Ghalehbaghi; Amir Hassankhani; Yasaman Aarabi; Afrooz Haghdoost
Journal:  Rheumatol Int       Date:  2015-08-08       Impact factor: 2.631

3.  Pain Processing and Vegetative Dysfunction in Fibromyalgia: A Study by Sympathetic Skin Response and Laser Evoked Potentials.

Authors:  Marina de Tommaso; Katia Ricci; Giuseppe Libro; Eleonora Vecchio; Marianna Delussi; Anna Montemurno; Giuseppe Lopalco; Florenzo Iannone
Journal:  Pain Res Treat       Date:  2017-09-28

4.  Effects of vitamin D optimization on quality of life of patients with fibromyalgia: A randomized controlled trial.

Authors:  Alireza Mirzaei; Mozhdeh Zabihiyeganeh; Seyed Adel Jahed; Elnaz Khiabani; Marzieh Nojomi; Salman Ghaffari
Journal:  Med J Islam Repub Iran       Date:  2018-04-05

5.  Fibromyalgia diagnostic model derived from combination of American College of Rheumatology 1990 and 2011 criteria.

Authors:  Banafsheh Ghavidel-Parsa; Ali Bidari; Asghar Hajiabbasi; Irandokht Shenavar; Babak Ghalehbaghi; Omid Sanaei
Journal:  Korean J Pain       Date:  2019-04-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.